Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis.

Scoville BA, Segal JH, Salama NN, Heung M, Bleske BE, Eyler RF, Mueller BA.

Ren Fail. 2019 Nov;41(1):118-125. doi: 10.1080/0886022X.2019.1585371.

2.

Clinical Pharmacology of Antibiotics.

Eyler RF, Shvets K.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1080-1090. doi: 10.2215/CJN.08140718. Epub 2019 Mar 12.

PMID:
30862698
3.

Use of feedback to improve mental number line representations in primary care clinics.

Eyler RF, Cordes S, Szymanski BR, Fraenkel L.

BMC Med Inform Decis Mak. 2018 Jun 20;18(1):40. doi: 10.1186/s12911-018-0618-6.

4.

Thrombolysis for Massive Pulmonary Embolism in Pregnancy.

Heavner MS, Zhang M, Bast CE, Parker L, Eyler RF.

Pharmacotherapy. 2017 Nov;37(11):1449-1457. doi: 10.1002/phar.2025. Epub 2017 Oct 10. Review.

PMID:
28891082
5.

Utilization of Continuous "Spinners" to Communicate Risk.

Eyler RF, Cordes S, Szymanski BR, Fraenkel L.

Med Decis Making. 2017 Aug;37(6):725-729. doi: 10.1177/0272989X17707198. Epub 2017 May 10.

6.

Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic Polymorphisms.

Shi J, Wang X, Eyler RF, Liang Y, Liu L, Mueller BA, Zhu HJ.

Basic Clin Pharmacol Toxicol. 2016 Dec;119(6):555-561. doi: 10.1111/bcpt.12625. Epub 2016 Jul 21.

7.

Psychotherapeutic Agents in End-Stage Renal Disease.

Eyler RF, Unruh ML, Quinn DK, Vilay AM.

Semin Dial. 2015 Jul-Aug;28(4):417-26. doi: 10.1111/sdi.12370. Epub 2015 Apr 6. Review.

PMID:
25857865
8.

In vitro glucose kinetics during continuous renal replacement therapy: implications for caloric balance in critically ill patients.

Stevenson JM, Heung M, Vilay AM, Eyler RF, Patel C, Mueller BA.

Int J Artif Organs. 2013 Dec;36(12):861-8. doi: 10.5301/ijao.5000232. Epub 2013 Oct 2.

PMID:
24366837
9.

Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltration.

Eyler RF, Vilay AM, Nader AM, Heung M, Pleva M, Sowinski KM, DePestel DD, Sörgel F, Kinzig M, Mueller BA.

Antimicrob Agents Chemother. 2014;58(3):1320-6. doi: 10.1128/AAC.02090-12. Epub 2013 Dec 9.

10.

Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.

Eyler RF, Heung M, Pleva M, Sowinski KM, Park PK, Napolitano LM, Mueller BA.

Pharmacotherapy. 2012 Dec;32(12):1061-9. doi: 10.1002/phar.1151.

11.
12.

Antibiotic dosing in critically ill patients with acute kidney injury.

Eyler RF, Mueller BA; Medscape.

Nat Rev Nephrol. 2011 Apr;7(4):226-35. doi: 10.1038/nrneph.2011.12. Epub 2011 Feb 22. Review.

PMID:
21343897
13.

Antibiotic pharmacokinetic and pharmacodynamic considerations in patients with kidney disease.

Eyler RF, Mueller BA.

Adv Chronic Kidney Dis. 2010 Sep;17(5):392-403. doi: 10.1053/j.ackd.2010.05.007. Review.

PMID:
20727509
14.

Vancomycin use during left ventricular assist device support.

Eyler RF, Butler SO, Walker PC, DePestel DD, Spoor MT, Pagani FD, Malani PN.

Infect Control Hosp Epidemiol. 2009 May;30(5):484-6. doi: 10.1086/597231.

PMID:
19301984

Supplemental Content

Loading ...
Support Center